Brian DeSchuytner

Insider Reports History

Location
Cambridge, MA
Signature
/s/ Alejandra Carvajal, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Brian DeSchuytner:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Mersana Therapeutics, Inc. SVP, COO & CFO Restricted Stock Unit 58.3K $158K $2.71 Jan 15, 2024 Direct
Mersana Therapeutics, Inc. SVP, COO & CFO Common Stock 121K $70.4K $0.58 Jan 16, 2025 Direct
Mersana Therapeutics, Inc. SVP, COO & CFO Restricted Stock Unit 62.5K $36.3K $0.58 Jan 15, 2025 Direct
Mersana Therapeutics, Inc. SVP, COO & CFO Stock Option (Right to Buy) 281K Jan 15, 2025 Direct

Insider Reports Filed by Brian DeSchuytner

Symbol Company Period Transactions Value $ Form Type Date Filed Role
MRSN Mersana Therapeutics, Inc. Jan 15, 2025 7 -$4.91K 4 Jan 17, 2025 SVP, COO & CFO
MRSN Mersana Therapeutics, Inc. Jan 14, 2025 3 -$1.47K 4 Jan 16, 2025 SVP, COO & CFO
MRSN Mersana Therapeutics, Inc. Jan 13, 2025 3 -$2.45K 4 Jan 15, 2025 SVP, COO & CFO
MRSN Mersana Therapeutics, Inc. Oct 1, 2024 4 -$27.2K 4 Oct 7, 2024 SVP, COO & CFO
MRSN Mersana Therapeutics, Inc. Jan 13, 2024 11 -$25.3K 4 Jan 17, 2024 SVP, COO & CFO
MRSN Mersana Therapeutics, Inc. Sep 5, 2023 1 $0 4 Sep 7, 2023 SVP, COO and CFO
MRSN Mersana Therapeutics, Inc. Jan 13, 2023 9 -$29.5K 4 Jan 18, 2023 SVP, Chief Financial Officer
MRSN Mersana Therapeutics, Inc. Jan 14, 2022 5 $0 4 Jan 19, 2022 Chief Financial Officer